BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• PolyPid Ltd. Raises $2.4 Million in Third Round of Financing

  January 7, 2013

   · 

  3 min read
• Biotech Beach

  Aviir, Inc. Release: Peer Reviewed Clinical Study Shows New Blood Test More Accurately Predicts Risk of a Heart Attack

  January 7, 2013

   · 

  5 min read
• 40% of Lung Cancer Cases Among Singaporeans can be Treated Genetically Compared With 5% of Caucasians: Human Genome Organization, The (HUGO)

  January 7, 2013

   · 

  4 min read
• Deals

  BioTime Signs Definitive Agreement With Geron Corporation Regarding Stem Cell Assets

  January 7, 2013

   · 

  1 min read
• Business

  Auxilium Pharmaceuticals Announces Expansion of Its Exclusive License for XIAFLEX® (CCH) to Include the Potential Treatment of Cellulite as an Additional Indication

  January 7, 2013

   · 

  5 min read
• BioMidwest

  Neuros Medical, Inc. Develops Implantable Device for Chronic Pain Applications

  January 7, 2013

   · 

  1 min read
• Pharm Country

  Echo Therapeutics (Nasdaq: ECTE) Provides an Update to Shareholders

  January 7, 2013

   · 

  6 min read
• Drug Development

  Peregrine Pharmaceuticals, Inc. Provides Update on the Internal Review of Its Phase II Second-Line Non-Small Cell Lung Cancer Trial

  January 7, 2013

   · 

  6 min read
• Biotech Bay

  Second Genome Sponsors American Gut Initiative to Identify Links Between Type 2 Diabetes and the Human Microbiome

  January 7, 2013

   · 

  2 min read
• Drug Development

  Celgene International Sárl Release: Apremilast ESTEEM Program Meets Primary and Major Secondary Endpoint in Pivotal Phase III Psoriasis Trials

  January 7, 2013

   · 

  1 min read